We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App





Abbott Presents Diagnostic Innovations to Enhance Patient Care at AACC 2022

By LabMedica International staff writers
Posted on 20 Jul 2022
Print article
Image: Abbott celebrated 50 years of diagnostic innovations at AACC 2022 (Photo courtesy of Abbott)
Image: Abbott celebrated 50 years of diagnostic innovations at AACC 2022 (Photo courtesy of Abbott)

Abbott Diagnostics (Lake Bluff, IL, USA) is offering one-on-one and group demonstrations of its latest diagnostic offerings at the 2022 AACC Clinical Lab Expo, including its next generation of Alinity systems that are designed to simplify diagnostics and help deliver results. In addition, Abbott will be providing demonstrations of its GLP systems Track, AlinIQ Digital Health solutions, hematology, molecular, diabetes care and point of care solutions.

Visitors at the Abbott AACC 2022 booth can learn new ways to achieve measurably better healthcare performance with its personalized core diagnostics solutions consisting of Resourceful Advocates, Harmonized Systems and Intelligent Insights. During its product demonstrations at the event, visitors can explore Abbott's next generation of Alinity systems that uses technology to help redefine and improve operational productivity and confidence in the laboratory. The Alinity family is harmonized across key laboratory disciplines, streamlining critical interactions between individuals, systems and information, and enabling users to redefine performance in the laboratory and across the institution.

The Alinity family comprises the Alinity ci-series integrated clinical chemistry & immunoassay system combining up to four modules in multiple configurations to meet the laboratory's needs and maximize operational efficiency. The Alinity c is a compact clinical chemistry system that maximizes testing throughput with high-quality assays to deliver efficient and accurate performance. The ALINITY I is a compact immunoassay system that utilizes proven CHEMIFLEX chemiluminescent detection technology to provide greater confidence in results. The Alinity m is a fully integrated, automated, high-throughput molecular diagnostics analyzer with high-quality assays that delivers the next level of flexibility and efficiency to molecular labs.

At AACC 2022, Abbott is also demonstrating GLP systems Track that allows users to easily modify their track for future changes and maximize floor space while transforming the laboratory from 2D to 3D. GLP systems Track minimizes track implementation time, maximizes uptime with infinite redundancy, optimizes workflow, and decreases turnaround time system to meet the laboratory’s needs. In addition, Abbott will demonstrate how AlinIQ Always On services can help labs achieve operational efficiency and increase productivity by avoiding unexpected downtime. AlinIQ Always On Services utilizes Active Sense Technologies, Resourceful Advocates and Disciplined Processes to offer instrument health monitoring that enables laboratories to achieve operational efficiency and increase productivity.
 

Related Links:
Abbott Diagnostics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.